Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Non-Current Deffered Revenue (2022 - 2025)

Core Laboratories' Non-Current Deffered Revenue history spans 4 years, with the latest figure at $29.4 million for Q4 2025.

  • For Q4 2025, Non-Current Deffered Revenue fell 5.57% year-over-year to $29.4 million; the TTM value through Dec 2025 reached $29.4 million, down 5.57%, while the annual FY2025 figure was $29.4 million, 5.57% down from the prior year.
  • Non-Current Deffered Revenue reached $29.4 million in Q4 2025 per CLB's latest filing, down from $31.1 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $31.8 million in Q4 2022 to a low of $29.2 million in Q1 2025.
  • Average Non-Current Deffered Revenue over 4 years is $30.4 million, with a median of $30.5 million recorded in 2023.
  • Peak YoY movement for Non-Current Deffered Revenue: increased 8.44% in 2024, then decreased 5.57% in 2025.
  • A 4-year view of Non-Current Deffered Revenue shows it stood at $31.8 million in 2022, then fell by 3.99% to $30.5 million in 2023, then increased by 1.87% to $31.1 million in 2024, then dropped by 5.57% to $29.4 million in 2025.
  • Per Business Quant, the three most recent readings for CLB's Non-Current Deffered Revenue are $29.4 million (Q4 2025), $31.1 million (Q3 2025), and $29.6 million (Q2 2025).